Description
Laboratory diagnosis of hepatitis C (HCV) is based on the detection in human blood serum of specific markers – antibodies to hepatitis C virus proteins (antigens) belonging to immunoglobulins (anti-HCV, IgM and anti-HCV, IgG), as well as the pathogen's nucleic acid (HCV RNA).
Anti-HCV (IgM) are specific class M immunoglobulins indicating possible infection or process reactivation; they are a marker of the early stage of infection. The test is intended to clarify the activity of the process, the stage of the disease, and to monitor treatment in combination with other investigations.
Period of execution
Within 8 days. The specified time does not include the day of biomaterial collection
Biomaterial type